Brick & Kyle Associates reduced its stake in AbbVie Inc (NYSE:ABBV) by 5.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 46,300 shares of the company’s stock after selling 2,567 shares during the period. AbbVie accounts for 3.4% of Brick & […]
